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The relevance of zinc determination in amniotic fluid
2nd Communication: Zinc in cases of high fetal risk
G. Kynast, E. Saling, N. Wagner
The importance of an adequate zinc supply to
mother and fetus for an undisturbed pregnancy is
undisputed today. By means of experiments on
animals fed on a low-zinc diet it was possible to
provoke a large number of diseases and syndromes.
Malnutrition tests on rats showed neurological
malformations (exencephalus, hydrocephalus),
tissue abnormalities, high deformity rate of
practically all organs and parts of the body and
greatly reduced birthweights [8, 17]. In addition
to obvious malformations such äs clubbed feet and
scull deformities, other not so obvious defects
such äs mucosa-defects can be observed in the
oesophagus [2], When the rats had been previously
fed on a low-zinc diet, there was a very noticeable
reduction in the mating desire of the females and
in the other cases the already high rates of abortion
increased so much that no healthy animals were
born at all [1]. Low-zinc feeding after the birth of
the rats gives rise to reduction in the milk-pro-
duction. The milk produced is low in zinc and the
serum-zinc levels fall rapidly in the young rats.
This results in diminished growth and increased
mortality [12]. The mostimportantresultemerging
from these tests is however that the pregnant rat
is clearly not able to störe up enough zinc (Zn) to
balance out a longer non-recipient period and to
supply the fetus with the stored-up zinc [9]. Severe
consequences are shown to occur after even only
one or two weeks of a low-zinc diet [8]. Tests
made on pregnant cows, to whom radiozinc
(65 Zn) had been administered, produced im-
portant Information on this point. Within a week
only 14% of the absorbed radiozinc was supplied
to the fetus and the plazenta by the mother [7],
Further tests on other animal species did not
supply any results contrary to those* given above
[6]. As in rats [9], in human beings the liver —
which is reckoned äs being one of the organs most
rieh in zinc — also does not appear to act äs a zinc
storage unit [6, 18]. There exists a direct pro-
portionality between the zinc level of the mother's
and the fetus's liver, than means, when the zinc
concentration diminishes in the liver tissue in the
mother then is also diminishes in the fetal liver
tissue [15].
The facts listed go further to prove that precisely
during pregnancy an alimental zinc deficiency can
very quickly bring about a general zinc inadequacy
Situation. However up to now there exist no
possibilities of recognizing such inadequacy situ-
ations in good time, let alone treating them.
l Objectives
The examination had to be made in order to
establish to what extent there exists a correla-
tion between fetal malnutrition, zinc content and
also the total protein content of the amniotic fluid
(AF). For this purpose test methods described in
Part I of this communication were adopted [10].
These were atomic absorption spectrophotometry
for the zinc measurement and a Biuret method
adapted for the amniotic fluid for the total protein
measurement. Risk-collectives had to be examined
and the results compared with a control group. In
this way an answer wasto be found to the question
äs to whether the allocation of zinc and possibly
also protein in the amniotic fluid are suitable
methods of early detection of fetal risk factors.
Through examination of particular risk-groups it
had to be proved which factors change the amniotic
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fluid zinc level (AFZL), what these changes are, corresponding levels in the control groupwiththe
and whether a differentiation can be undertaken help of the U-test according to MAN, WHITNEY
äs to the initial cause. In this way conditions for a and WILCOXON. For those groups in Tab. I where
therapeutical Intervention should be established. the number of cases was too small, only the trend
was established. In order to allow a differentiation
between hypo- and hypertrophic fetuses, the birth
weight, dependent on the WG was in each case
More than 500 deep-frozen (-20°C) amniotic provided by a percentile Status symbol according
fluid samples were available for the investigations. to SALING (still not published) using NICKL'S [13]
The samples were obtained by amniocentesis intrauterine weight Standards. Fig. l shows this
during pregnancy, by puncturing the membrane to scheme äs developed in our clinic. According to
induce the birth or during the course of delivery. this, normal cases receive the symbol P IV. They
In contrast to serum and red cell zinc levels [11], lie between the 25 th and 75th percentile level.
the AFZL are not supposed to be dependent on the Severely hypotrophic fetuses however, lying below
age of the mother [10], and therefore it was not the 3rd percentile receive the symbol P I-. Fig. 2
necessary to make an age composition. Each case shows the median of the AFZL dependent on the
^from which amniotic fluid was available was WG. The median curve of the control group was
examined to see if anything unusual had oecurred derived from 230 amniotic fluid samples from
during the pregnancy and during the newborn different patients. The median curve for severe
period. All cases which veered away from the hypotrophy covers 42 cases with the percentile
normal pregnancy course were assigned to the Status P I-, whereas the curve of the zinc level
corresponding risk-collectives. The diagnoses listed of all the hypotrophic cases covers 140 tests of
in Table I belonged to this group. hypotrophy of all levels of severity. According to
the U-test the zinc levels of the amniotic fluid in
Tab. I. Syndromes which were examined for deviations in cases of mfld or «VW« hypotrophy from the 38 th
the zinc level of the amniotic fluid. WG onwards are significantly lower (p < 0,01)
Hypotrophic newborns Diabetes meUitus than *OSe °fjhe comParison 'OÜective. It IS not
(different classes) possible to differentiate statistically between cases
Hypertrophie newborns of mild and severe hypotrophy. The difference in
£££%_*** SSZSS, fluid »· -*« levels of normal and hypotrophy
 cases
hydrocephalus, spinabifida, Hemorrhagic AF from the 38th WG onwards lies at about 0,05 %
hydrocele, lunghypoplasie, etc.) Intrauterine fetal death Zn/ml AF.
Suitable experiments were undertaken to clarify
All cases which were not assigned to a group listed the question äs to whether differences can also
in Tab. I, that is whose pregnancy course was not be established in the overall protein levels of the
unusual, were included in the control group. The amniotic fluids between cases of hypotrophic
main indications for sampling the amniotic fluid fetuses and the comparison collective. The results
in these patients were: Diagnosis of lung-maturity, are shown in Fig. 3 with the median levels of the
premature labour, high rupture of the membrane, control group compared to the hypotrophy cases
genetic examinations and tocolysis. (P I- to P III-). A significant difference is not to
For each syndrome examinations of the correlation be found. The comparison on cases of severe hypp-
of the weeks of gestation (WG) were made - in so trophy (P I-) provided a similar picfure. The
far äs there were enough cases available. This group control group of 197 pregnancies was compared
included: Hypotrophic fetuses, diabetes mell., with 123 cases of hypotrophy at all levels of
gestosis and cases with green amniotic fluid. For severity.
these cases the median values and the lOth and Fig. 4 shows the AFZL in patients with gestosis
90th percentües were reckoned. For statistical or diabetes mell. compared to the control group
investigation the results were compared with the dependent on the WG. 36 cases of EPH-gestosis
J. Perinat. Med. 7(1979)
Kynast et al., Zinc determination in amniotic fluid. II. 71
PERCENTILE STATUS
normal l /rypertroph l ftypotroph






































































































































































Fig. 1. Percentile Status according to SALING (still not published) using NlCKL's [13J intrauterine weight Standards.
at various levels were examined. The course of
the curve differs clearly from that of the control
group and the diabetics. About the 32nd to 33rd
WG the AFZL in the gestosis group are signifi-
cantly higher (p < 0,05) than in the control group.
They then sink not only relatively in comparison
with the control group but also totally, and about
the 40 th to 41 st WG lie significantly below the
corresponding levels of the control group (p<0,05).
The examination of 61 patients with diabetic
metabolism however produced a different result.
As shown in Fig. 4 the curve for the diabetics lies
under the control group in all the pregnancy
periods examined. The difference is significant
J. Perinat. Med. 7 (1979)
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Fig. 2. Zinc content of the amniotic fluid dependent on
the week of pregnancy in cases of hypotrophy compared
to the control group.
Fig. 4. Zinc content of the amniotic fluid dependent on
the week of pregnancy in cases of gestosis or diabetes
mellitus compared to the control gro p.





28.-31. 32r-33. 34.-S5. 3Θ.-37. 38.-39. 40-41. 42-43
week of gestation
O——-O protein values in.control group
φιβββφ protein values in cases of hypotrophy
Fig. 3. Total protein content of the amniotic fluid de-
pendent on the week of pregnancy in cases of hypotrophy
compared to the control group.
(p < 0,05) after the 39th WG. The differences in
median levels measure about 0,05 μg Zn/nd AF.
As guideline, the protein content of the amniotic
fluid was also calculated in cases of gestosis and
diabetis mellitus. Without carrying out statistical
analysis, a tendency to higher levels in the middle
trimenon was recognised in the gestosis group s
against lower levels in the control group from the
38 th WG onwards. In the diabetic group lowered
protein levels were measured in the whole period
between the 28th and 43rd WG.
In Fig. 5 the zinc levels obtained from clear fluid
samples or that containing vernix are compared
with the zinc content of 98 cases where mekonium
was contained in the amniotic fluid. The result was
that from the 38th WG onwards the zinc content
of the green amniotic fluid lies significantly higher
(P < 0,05).
In further groups of risk pregnancies, where how-
ever the n mber of cases was too small to under-
take statistical calculations, the following tenden-
cies were seen to emerge: In 9 cases of twin preg-
J. Perinat. Med. 7 (1979)
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Fig. 5. Zinc content of the amniotic fluid dependent on
the week of pregnancy in amniotic fluid contaiiiing
meconium, compared to the control group.
nancies the examination of the amniotic fluid for
zinc content gave levels which lay between the
20th and 50th percentile level of the control
group. In one case with two amniotic cavities the
amniotic fluid examination gave almost identical
zinc levels for both samples. Two cases of hydram-
nion showed lower levels. In 5 cases of intra-
uterine fetal death a tendency towards higher
zinc levels could be established, particularly when
the death of the fetus had taken place some days
previously. The examination of 16 hemorrhagic
amniotic fluid samples brought no increased zinc
levels.
3 Discussion
The investigations prove that the significant in-
crease in the zinc content of the amniotic fluid
after the 37th WG to about three times the initial
level [10] in cases of mild or severe hypotrophy
occurs only to a lesser degree, so that towards
the end of the third trimenon the AFZL lie clearly
below those in the control group (Fig. 2).
Since the zinc level calculation through atomic
absorption spectrophotometry is quick, precise
and specific it opens up new possibilities for the
complete biochemical control of the fetal condition.
Cases of various types of gestosis and diabetis mell.
at various classes which occur very often in the
pregnancy risk-collective, cause — äs does hypo-
trophy — a reduction in the rise of the AFZL (Fig.
4). In future the zinc level measurement could be
included äs a complementary diagnosis for all these
syndromes. Increased AFZL were observed in our
tests after the 36th WG only in green amniotic
fluid and intrauterine fetal death, both of which
conditions can be easily recognized. The lOth
percentile of the control group runs at 0,04 Mg
Zn/ml AF in the 37th WG, and reaches a level of
0,14 Mg Zn/ml AF in the 42nd. Thus levels lying
below this line during this period can be regarded
äs suspect due to negative influences through
hypotrophy, diabetis mell. or gestosis. HAHN and
FucHs[4]intheir investigation on the zinc content
of the serum, proved that from the 36 th WG on-
wards the serum zinc level in women with severe
gestosis decreases more sharply than in normal
cases. From the 36 th WG on, this difference is
significant at p < 0,01. The mean value reaches
its minimum in the 40th WG with 0,59 Mg Zn/ml
serum. So there is similar behaviour of zinc concen-
tration in the serum of the mother and the amniotic
fluid, with the difference that the zinc content of
the serum does not increase in late pregnancy in
the control groups, whereas a rise can be established
in the AFZL. The reaction of the trace element
copper in the mother's serum in cases of gestosis
however shows a completely opposite picture. A
report of the copper content of the amniotic fluid
will be published later.
The authors named [4] explain the decrease in the
serum zinc level with the high loss of protein of
gestosis patients during pregnancy. This applies
particularly to the loss of albumin to which a third
of the zinc in the serum should be combined. The
same explanation could be applied to the decrease
of AFZL in cases of gestosis after the 39th WG.
It is well known that the fetus produces urine in
J. Perinat. Med. 7(1979).
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large quantities during the third trimenon. There-
fore äs a reason for the significantly increased
AFZL of gestosispatients around the 32nd WG the
possibility arises that correspondingly the mother's
and fetal urine contain an increased proportion of
protein, and together with it the zinc is discharged
at increased levels. As a result during the further
course of pregnancy a zinc deficiency occurs with
corresponding decrease of the AFZL.
In a previous work [10] the interdependence of the
protein content of the amniotic fluid and gestational
week was determined. Thereafter the protein level
decreased clearly up to the 39th WG, and then
remained more or less constant. In a similar test on
the control group undertaken for this work, for
which not five but rathertwo WGs were combined,
«there emerged a tendency to an increase of the
protein content of the amniotic fluid after the
38th WG; however, this tendency could not be
statistically supportedbecause of the wide variations.
Nevertheless FENNEFROHN [3] was able to prqve
a significant increase in protein and albumin after
the 38th WG. Thus it appears proven that towards
the end of a pregnancy the zinc and protein content
of the amniotic fluid react similarly in principal.
The important function of zinc against bacterial
activity of the amniotic fluid is well known. It is
thought that zinc due to its similar ionic radius
and Charge interferes in the magnesium dependent
biosynthesis Steps of the metabolism of the
bacteria. Therefore it is also understandable that
a higher phosphate content in the amniotic fluid
due to the development of unsoluble zinc phos-
phate has a negative effect on the bacteriostasis.
After the results of the previous work, the question
is posed äs to whether the observed decrease in
the zinc content of the amniotic fluid in the
various diseases and syndromes tested, produces
yet another additional danger to the fetus due to
the increased risk of a bacterial infection. Further
tests must provide clarity on this point. It remains
to be proved in how far the zinc calculation can
be applied äs an indicator of a threatened intraut-
erine infection and thereby increased danger of
intrauterine fetal death. The observation made by
TAFARI et al. [16] that in almost one third of all
perinatal deaths in a tested collective in Addis
Abeba an inadequate bacteriostasis of the am-
niotic fluid was established, gives certain indications
in this direction.
The original idea that zinc deficiency in human
nutrition through the widespreading of this trace
element is not to be expected, had to be revised
after the investigations made by HALSTED et al.
[5] and REINHOLD et al. [14]. Insufficient zinc
supply to the organism leads among many other
disturbances to a diminished growth or even to
dwarfism. Many experiments made on animals
and tests made on human beings have proved that
the human organism has a very limited storage
capacity and no real storage organ for zinc. The
conclusion, that zinc deficiency in pregnancy can
lead to diminished growth of the fetus is not
far off. Therapeutical tests have shown that zinc
deficiency caused by malnutrition and even some
diseases and syndromes react quickly and success-
fully to an oral or parental zinc 'therapy. Should it
later be possible to recognize zinc deficiency early
in pregnancy, then the outlook appears quite
favourable for therapeutic interventions.
Summary
Extensive tests on animals and tests on human beings
have established that the storage capacity of the organism
for zinc (Zn) is very limited and that there exists no
proper storage organ for this trace element. Particularly
during pregnancy a nutritional zinc deficiency therefore
quickly brings about a general zinc deficiency Situation.
Up to now however it has not been possible to recognize
these deficiencies in time, let alone to treat them. In this
investigation we tested to what extent there exists a
correlation between fetal malnutrition and the zinc
content or total protein content in the amniotic fluid
(AF). For this purpose we used methods described in
Part I of this publication [10J. These were atomic ab-
sorption spectrophotometry for the zinc measurement
and a Biuret method adapted for the amniotic fluid for
the total protein measurement.
Various risk-collectives were examined and the results
were compared with 230 cases of a control group. The
results show, that the significant increase in the zinc
content of the amniotic fluid in the control group from
the 38 th week of gestation (WG) onwards to about three
times äs much äs the initial level, occurred only in weak
form in 123 cases of mild or severe hypotrophy. So 'the
amniotic fluid zinc levels (AFZL) lie clearly lower towards
J. Perinat. Med. 7 (1979)
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the end of the third trimenon than in the control group.
The difference according to the U-test at p < 0,01 is
significant. The concentration difference from the 38th
WG onwards lies at about 0,05 Mg Zn/ml AF.
The calculation of the total proteincontentof the amniotic
fluid does not appear tobe a suitable method of recognizing
a hypotrophy, since it doesnot show a significant difference
from the control collective. However, towards the end of
the pregnancy zinc and protein content show the same
tendency. 36 cases with EPH-gestosis showed — in
comparison with the control group - around the 32nd
to 33rd WG significantly higher, and around the 40 th
to 41 st WG significantly lower levels of zinc (p < 0,05).
The explanation for this is in our opinion due to the in-
creased protein mobilisation following the protein loss,
which, on account of the high albumin linking of zinc, is
combined with a zinc loss.
However tests on the amniotic fluid of 61 patients with
diabetic metabolism conditions brought another result.
Here zinc levels lie below those of the control group
during the complete pregnancy period tested. After the
39th WG the difference is significant (p < 0,05). The
lOth percentile of the control group goes up to 0.04 Mg
Zn/ml AF in the 37 th WG and reaches the level of 0,14
Mg Zn/ml AF in the 42nd week. Levels lying below this
line can be regarded äs suspect due to negative in-
fluences through hypotrophy, diabetis mell. or gestosis.
Increased AFZL occur after the 34 th WG only in cases of
intrauterine fetal death or green amniotic fluid. Further-
more zinc has an important function for the antibacterial
activity of the amniotic fluid. For example, the zinc levels
of the amniotic fluid are reduced in the amnionic in-
fection syndrome. Therefore the calculation of the AFZL
could be of importance to the early diagnosis of such
infections.
The longheld viewthat zinc deficiency in human nutrition
is not to be expected through the widespreading of this
trace element, must be revised today. Insufficient zinc
supply to the organism clearly leads - among other
disturbances - to a diminished growth, which according
to the foregone investigations also appears to have a great
importance on pregnancy. Experiments on animals and
therapy tests on groups of people with zinc deficiency
supply have shown that the alimentary zinc deficiencies
and even some medicinal or disease disturbances do
respond quickly and successfully to an oral or parental
zinc therapy. An early detection of zinc deficiency during
pregnancy could therefore open new possibilities of
treatment.
Keywords: Amniotic fluid, diabetes mellitus, fetal supervision, gestosis, hypotrophy, malnutrition, proteins, risk
pregnancy, zinc.
Zusammenfassung
Die Bedeutung der Zinkbestimmung im Fruchtwasser.
H. Mitteilung: Die Bestimmung von Zink im Falle fetaler
Gefährdung.
Umfangreiche Tierversuche und Untersuchungen am
Menschen haben bewiesen, daß die Speicherfähigkeit
des Organismus für Zink (Zn) sehr begrenzt ist und es
kein eigentliches Speicherorgan für dieses Spurenelement
gibt. Gerade in der Schwangerschaft führt ein alimentärei
Zinkmangel deshalb schnell zu einer allgemeinen Zink-
mangelsituation. Bis heute fehlen jedoch die Möglich-
keiten, solche Mangelzustände rechtzeitig zu erkennen
oder gar zu therapieren. In der vorliegenden Arbeit wird
untersucht, inwieweit eine Korrelation zwischen fetaler
Mangelversorgung und dem Zinkgehalt bzw. dem Gehalt,
an Gesamt-Protein des Fruchtwasser (AF) besteht.
Hierzu wurden die im Teil I dieser Veröffentlichung
beschriebenen Untersuchungsmethoden angewandt [10].'
Es wurden verschiedene Risikokollektive untersucht
und die Ergebnisse mit 230 Fällen einer Kontrollgruppe
verglichen. Die Ergebnisse zeigen, daß der im Kontroll-
kollektiv signifikante Anstieg des Zinkgehaltes des AF
nach der 37. Schwangerschaftswoche (GW) auf etwa
das dreifache des Ausgangswertes bei 123 Fällen von
leichter oder schwerer Hypotrophie nur in abgeschwäch-
ter Form erfolgt, so daß die Fruchtwasserzinkwerte
(AFZL) gegen Ende des dritten Trimenons deutlich tiefer
liegen als in der Kontrollgruppe. Der Unterschied ist nach
dem U-Test mit p < 0,01 signifikant. Die Konzentrations-
differenz liegt von der 38. GW ab bei etwa 0,05 Mg Zn/ml
AF.
Die Bestimmung des Gesamtproteingehaltes des AF er-
scheint nicht als geeignete Methode zur Erkennung
einer Hypotrophie, da sich zum Kontrollkollektiv keine
signifikanten Unterschiede ergeben.
36 Fälle mit EPH-Gestose zeigten im Vergleich zur
Kontrollgruppe im Bereich der 32. bis 33. GW signifi-
kant erhöhte, im Bereich der 40. bis 41. GW signifikant
tiefere Werte (p < 0,05). Die Erklärung hierfür ist unserer
Meinung nach die erhöhte Eiweißmobilisierung und der
nachfolgende Eiweißverlust, der aufgrund der hohen
Eiweißbindung des Zn mit einem Zinkverlust kombiniert
ist.
Die Untersuchung des AF von 61 Patientinnen mit
diabetischer Stoffwechsellage erbrachte dagegen ein
anderes Ergebnis. Hier liegen die Zinkwerte im ge-
samten untersuchten Schwangerschaftsbereich unter
denen der Kontrollgruppe, nach der 39. GW ist der
Unterschied signifikant (p < 0,05). Die 10. Perzentüe
der Kontrollgruppe verläuft in der 37. GW bei 0,04 Mg
Zn/ml AF und erreicht in der 42. GW den Wert 0,14 Mg
Zn/ml AF. Darunterliegende Werte können als suspekt
hinsichtlich negativer Einflüsse durch Hypotrophie,
Diabetes mellitus oder Gestose angesehen werden. Er-
höhte AFZL treten nach der 34. GW nur bei Fällen von
infans mortuus auf. Zn hat eine wichtige Funktion für die
antibakterielle Aktivität des AF. So sind z. B. beim
Amnioninfektionssyndrom die Zinkwerte des AF
reduziert. Die Bestimmung des AFZL könnte deshalb
füi die Früherkennung solcher Infektionen von Bedeu-
tung werden.
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76 Kynast et al., Zinc determination in amniotic fluid. II.
Die lange Zeit gültige Meinung, daß ein Zinkmangel
in der menschlichen Ernährung bei der weiten Ver-
breitung dieses Spurenelementes nicht zu erwarten ist,
muß heute revidiert werden. Mangelhafte Zinkver-
sorgung des Organismus fuhrt neben anderen Störungen
eindeutig zu einem verringerten Wachstum, was nach
den vorliegenden Untersuchungen auch für die Schwan-
gerschaft von großer Bedeutung zu sein scheint. Tierex-
perimente und Therapieversuche an zinkmangelversorg-
ten Bevölkerungsgruppen habemgezeigt, daß die alimentär
verursachten Z inkm angelzustände und sogar einige
medikamentöse oder krankheitsbedingte Störungen auf
eine orale oder paienterale Zinktherapie gut und schnell
ansprechen. Ein frühzeitiges Erkennen von Zinkmangel·
zuständen in der Schwangerschaft könnte somit neue
Möglichkeiten der Therapie eröffnen.
Schlüsselworte: Diabetes mellitus, Fetalüberwachung, Fruchtwasser, Gestose, Hypotrophie, Mangelentwicklung, Pro-
teine, Risiko schwangerschaft, Zink.
Resume
L'interet de la mesure du zinc dans le liquide amniotique.
2e Communication: Le zinc dans les cas de haut
risque foetal
Des tests effectues ä grande echelle sur des animaux et
d'autres sur des etres humains ont permis d'etablir que
la capacite de stockage de lOrganisme pour le zinc (Zn)
est tres limitee et qu'il n'existe pas d'organe de stockage
xpropre pour cet oligelement. Durant la grossesse en parti-
culier, une carence nutritive de zinc entraine rapidement
une carence generale de zinc qu'il n'a pas ete possible
jusqu'a maintenant de detecter a temps, encore nioinsde
soigner. C'est pourquoi nous nous sommes proposes dans
cette etude d'examiner le degre de correlation entre la
malnutrition foetale et la teneur en zinc ou la teneur totale
en proteine du liquide amniotique (LA); nous avons utilise
a cet effet des methodes decrites dans la Partie I de cette
publication [10]: la spectrophotometrie de l'absorption
d'atomes pour la mesure du zinc et une methode Biuret
adaptee au liquide amniotique pour la mesure totale de
proteine.
Les ex amen s ont p orte sur divers groupes ä risque, dont
les resultats ont ete compares avec 230 cas d'un groupe de
contröle.
Les resultats montrent que la hausse importante de la
teneur en zinc du liquide amniotique dans le groupe de
contröle a partir de la 38e semaine de gestation (Ge-
station Week 'WG') et atteignant jusqu'a trois fois le
niveau initial est apparue seulement sous forme affaiblie
dans 123 cas dTiypotrophie legere ou grave. C'est ainsi
que les taux de zinc dans le liquide amniotique (Amniotic
Fluid Zinc Levels: AFZL) sont nettement plus bas vers la
fin du troisieme trimestre que dans le groupe de contröle.
La difference conforme au «U-test» est significante a
p < 0,01. La difference de concentration relevee a partir
de la 38e semaine de gestation se situe aux alentours
de 0,05 Mg Zn/ml LA.
Le calcul de la teneur totale en proteine du liquide amnio-
tique ne semble pas etre une methode appropriee pour le
depistage d.une hypotrophie du fait qu'il ne montre
aucune difference importante avec le groupe de contröle.
Cependant, on releve une tendance identique entre la
teneur de zinc et de proteine vers la fin de la grossesse.
Compares au groupe de contröle, 36 cas de gestose EPH
ont fait etat de taux de zinc beaucoup plus eleves ä la
32-33e semaine de gestation et beaucoup plus bas
a la 40-41 e WG (p < 0,05). II nous semble que
cela estdüäla mobilisation accrüe de proteine consecutive
a la perte de proteine qui, a cause du haut degre de liaison
du zinc avec Fälbumine, se trouve combinee avec une
perte de zinc.
Neanmoins, des tests effectues sur le liquide amniotique
de 61 parturientes presentant des conditions de metabol-
isme diabetique ont donne un autre resultat. Les taux
de zinc se situent ici au-dessous de ceüx du groupe de
contröle tout au long de la periode de grossesse sous
observation. La difference est importante apres la
39« semaine de gestation (p < 0,05) Le IQe
percentüe du groupe de contröle monte jusqu'a 0,04
Mg Zn/ml LA dans la 37e semaine et atteint le taure
de 0,14 Mg Zn/ml LA dans la 42e semaine. Les taux
situes au-dessous de cette ligne peuvent etre consideres
comme suspects ä la suite d'influences negatives dües ä
Fhypotrophie, au diabetis mellitus ou a la gestose. Les
hausses des taux de zinc dans le liquide amniotique
apres la 34e semaine de gestation ne surviennent que
dans les cas de mort foetale intra-uterine ou de liquide
amniotique vert. De plus, le zinc a une fonction im-
portante pour l'activite antibacterielle du liquide
amniotique. Par exemple, les taux de zinc du liquide
amniotique sont reduits dans le syndrome d'infection
amniotique et le calcul de l'AFZL (taux du zinc dans le
liquide amniotique) pourrait donc aider a diagnostiquer
rapidement de telles infections.
II importe de reviser aujourd'hui la supposition admise
pendant longtemps et selon laquelle la carence de zinc
dans la nutrition humaine n'est pas a craindre etant donne
la presence etendue de cet oligelement. Un apport in-
suffisant de zinc dans lOrganisme provoque sans aucun
doute - putre d'autres trpubles - une cjroissance
atrophiee qui, selon les investigations anterieures, semble
avoir une grande influence sur la grossesse. Des experiences
animales et des tests therapeutiques effectues sur des
groupes de personnes atteintes d'une carence en zinc
ont montre que les deficiences alimentaires en zinc et
meine certains troubles medicaux ou maladifs peuvent
etre contrecarres rapidement et avec succes par une
therapie orale ou parenterale de zinc. Un depistage
precoce d'une carence en zinc en cours de grossesse
pourrait donc ouvrir de nouvelles possibilites de trait-
ement.
Mots-cles: Contröle foetal, diabetes mellitus, gestose, grossesse a risque, hypotrophie, liquide amniotique, malnutrition,
proteines, zinc.
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